Does treatment with rosiglitazone increase cardiovascular risk of patients with type 2 diabetes mellitus?
Gerstein
Hertzel C
HC
Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, ON, Canada. gerstein@mcmaster.ca
Yusuf
Salim
S